CDH1 and eyelid carcinoma: Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Somatic Mutations in <i>CDH1</i> and Other Clinically Actionable Mutations Imply Early Use of Targeted Agents.